Charles A. Reinhart
Director of Finance/CFO at PACIRA BIOSCIENCES, INC.
Net worth: 1 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kristen Williams | F | 50 | 13 years | |
| Paul Hastings | M | 64 | 13 years | |
| David Curiel | M | - |
Vectorlogics, Inc.
 Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | 26 years |
| Frank Lee | M | 56 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Gary Pace | M | 76 | 16 years | |
| Christopher Christie | M | 61 | 5 years | |
| Michael Yang | M | 62 | 1 years | |
| Anthony Molloy | M | 50 | - | |
| Mark Froimson | M | 63 | 7 years | |
| Abraham Ceesay | M | 46 | 1 years | |
| Alethia Young | F | 45 | 1 years | |
| Marcelo Bigal | M | - | 1 years | |
| Lauren Riker | F | 45 | 12 years | |
| Daryl Gaugler | M | 62 | 5 years | |
| Mark A. Kronenfeld | M | 69 | 11 years | |
| Laura Brege | F | 66 | 13 years | |
| Andreas Wicki | M | 64 | 18 years | |
| Max Reinhardt | M | 53 | 5 years | |
| Jonathan Slonin | M | 49 | 3 years | |
| Robert W. Holthausen | M | 76 |
The Wharton School of the University of Pennsylvania
| 35 years |
| Jeffrey Levin | M | - | 6 years | |
| Christopher C. Young | M | 52 | 1 years | |
| Susan Mesco | F | - | 9 years | |
| J. David Sakura | M | - |
Vectorlogics, Inc.
Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | - |
| Sara Ghazaii Marino | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David M. Stack | M | 72 | 17 years | |
| Philip MacNeill | M | 70 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| Dennis L. Winger | M | 77 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 14 years |
| Jason Keefer | M | 52 | 5 years | |
| Mitchel Sayare | M | 76 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| Scott Schaffner | M | 54 | - | |
| Kevin E. Moley | M | 77 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 7 years |
| Joel Rogers | M | 62 | 2 years | |
| Adam Blackman | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Mark Walters | M | 69 | 5 years | |
| Richard Scranton | M | 57 | 9 years | |
| Peter A. Friedli | M | 70 | 27 years | |
| Uwe Sommer | M | - | 1 years | |
| Lee Jeffrey Tawil | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Lawrence Berger | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Hyo Sang Lee | M | - |
Lehigh University
| 5 years |
| Michael Williams | M | - |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | - |
| Eric Siegel | M | 60 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 3 years |
| Vladimir Kharitonov | M | - | 13 years | |
| John Dawson | M | 64 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 11 years |
| Yvonne Greenstreet | M | 61 | 9 years | |
| Julie Shimer | M | 71 |
Lehigh University
| 4 years |
| Farid Harianto | M | 68 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Bryan Reasons | M | 56 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 6 years |
| Mike Sutter | M | - |
Lehigh University
| 9 years |
| Willi Miesch | M | 60 | 1 years | |
| Roy Winston | M | 63 | - | |
| Samson Tom | M | 51 | 1 years | |
| Michael Zagger | M | - | - | |
| Gene Vivino | M | - |
The Wharton School of the University of Pennsylvania
Lehigh University
| 6 years |
| Anthony Clarke | M | 68 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 4 years |
| Jamie Kramer | F | - |
The Wharton School of the University of Pennsylvania
| 12 years |
| Glenn Fuhrman | M | 58 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Charles Homcy | M | 75 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 6 years |
| Andrew Pearson | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Richard Sol Nackenson | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Alex Panos | M | - |
The Wharton School of the University of Pennsylvania
| 9 years |
| Timothy Wilmott | M | 66 |
Lehigh University
| 5 years |
| Vaughn M. Kailian | M | 79 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | - |
| Patrick Enright | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Scott Braunstein | M | 60 | 3 years | |
| James Scibetta | M | 59 | 9 years | |
| Louis A. Toth | M | - |
The Wharton School of the University of Pennsylvania
| 10 years |
| Jeffrey Runge | M | 67 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | - |
| Thomas Knapp | M | 71 | 2 years | |
| Luke Evnin | M | 60 | 7 years | |
| Tony DeSpirito | M | 55 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Randall Greene | M | 58 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Clinton Andrew Hess | M | 53 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Marc Ganzi | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Bruce C. Miller | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Gang Yu | M | 64 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Robert Stephen Venable | M | 61 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Rocco Tarasi | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Brian S. Dunn | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Somkiat Sirichatchai | M | 58 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Darrick L. Hills | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Heather Carrillo | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Steven Sean Hill | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Joseph Army | M | 60 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Marcos Rodriguez | M | 62 |
The Wharton School of the University of Pennsylvania
| 2 years |
| John Martin | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Paige Daly | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| John Petry | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jonathan Kelly | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Michael S. Castleman | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Ethan Scott Youderian | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Alan Macksey | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jeffrey Weiner | M | 54 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Eric S. Weinstein | M | 53 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Noel Crisman Boggan | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Stephen Kim | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Steven Jones | M | 59 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jose Teodoro Limcaoco | M | 62 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Kenneth Hern | M | 86 |
The Wharton School of the University of Pennsylvania
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
| United Kingdom | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles A. Reinhart
- Personal Network
